Related Experiment Video

Updated: Aug 23, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice

Gee W Lau1, Huimin Ran, Fansheng Kong

  • 1Division of Pulmonary and Critical Care Medicine, University of Cincinnati College of Medicine, 231 Albert Sabin Way, MSB 6006, Cincinnati, OH 45267-0564, USA. gee.lau@uc.edu

Infection and Immunity
|June 24, 2004
PubMed

Insights

Pseudomonas aeruginosa releases pyocyanin (PCN) during lung infections. This study shows PCN causes tissue damage and cell death in respiratory tract models.

Area of Science:

  • Microbiology
  • Pathogenesis
  • Respiratory Medicine

Background:

  • Pseudomonas aeruginosa is a common opportunistic pathogen, particularly in cystic fibrosis lung infections.
  • The bacterium produces pyocyanin (PCN), a redox-active phenazine compound.
  • PCN is known to affect cellular functions in lung epithelial cells in vitro.

Purpose of the Study:

  • To investigate the role of pyocyanin (PCN) in mediating tissue damage during respiratory tract infections.
  • To validate the pathogenic effects of PCN in relevant in vivo models.

Main Methods:

  • Utilized two distinct respiratory tract models of infection.
  • Assessed tissue damage and necrosis in the presence of PCN.

Main Results:

  • Demonstrated that pyocyanin (PCN) directly mediates tissue damage.
  • Confirmed PCN's role in inducing necrosis within the respiratory tract models.

Conclusions:

  • Pyocyanin (PCN) is a key virulence factor contributing to lung tissue damage and necrosis during Pseudomonas aeruginosa infections.
  • These findings highlight PCN as a potential therapeutic target for mitigating infection-induced lung injury.

More Related Videos

Pseudomonas aeruginosa Induced Lung Injury Model07:24

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...